the trends, innovative discoveries, and clinical data for cell&gene therapeutics to support the successful commercialization of therapeutic products.
and attendees from leading global CGT organizations, research institutes, and biotech companies.
in the development, the design, manufacturing, and CMC of AAV and the prospects of AAV gene therapy for rare and difficult to treat diseases.
in CAR-T treatment and how to leverage a variety of cell therapies to cope with the solid tumor and other diseases.
and how to maximize CRISPR technology to help patients with unmet medical need.
through innovation and optimization.
Immerse yourself in over 30 hours of valuable content, encompassing the latest advancements, cutting-edge research, and industry trends within the Cell and Gene Therapy field.
Gain insights from more than 20 comprehensive case studies, showcasing real-world applications and successful implementations of Cell and Gene Therapy strategies, providing practical knowledge and actionable takeaways.
Engage with over 50 renowned industry experts, thought leaders, and visionaries who will deliver thought-provoking presentations, sharing their expertise, experiences, and groundbreaking insights.
Take advantage of exclusive 1-on-1 meetups, fostering meaningful connections with industry professionals, peers, and potential collaborators, enabling invaluable discussions, partnerships, and knowledge exchange.
Immerse yourself in a dynamic and vibrant community of professionals, researchers, and innovators, providing ample networking opportunities to expand your professional circle, forge new partnerships, and explore collaborative endeavors.
Participate in interactive live question and answer sessions, allowing you to engage directly with speakers, seek clarification on key topics, and deepen your understanding of critical aspects related to Cell and Gene Therapy.
At BIOMAP, we place the utmost importance on maintaining high-quality standards and fulfilling our client's requirements at all our events. Our conferences are designed to bring together industry decision-makers and influencers, guaranteeing meaningful interactions and ensuring that participants make the most out of their time. We meticulously manage exhibition booths and branding opportunities, prioritizing exclusivity for partners who seek to accomplish their objectives through these channels.Become Sponsor
Biotech Connection Singapore (BCS) is a non-profit organisation that aims to promote and support entrepreneurship in life sciences, biotech, medtech and healthcare by forming a platform for academics, entrepreneurs, industry professionals as well as government agencies to interact and build connections.
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Using its proprietary RenMabTM/RenLite®/RenNano® mice platforms for fully human monoclonal, bispecific/multispecific antibody and nanobody development, Biocytogen has integrated its in vivo drug efficacy screening platforms and strong clinical development expertise to streamline the entire drug development process. Biocytogen is undertaking a large-scale project to develop first-in-class and/or best-in-class antibody drugs for more than 1000 targets, known as Project Integrum(RenMice® HiTS Platform). As ofJune 30, 2023, 50therapeutic antibody co-development/out-licensing/transfer agreements and 42target-nominatedRenMice® licensing projectshave been established worldwide, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen's pipeline is comprised of 10 core assets, with partnerships established for multiple clinical assets.
Huzhou Shenke Biotechnology Co., Ltd. (HZSKBIOⓇ) is a leading provider of standardized and customized quality control products for the biopharmaceutical industry. We offer high-quality QC solutions throughout the entire supply chain, from R&D to production. HZSKBIOⓇ successfully supported FDA, EMA and NMPA filings for our customers, and has established FDA type II Drug Master Files (DMF) for their regulatory submissions. Our products are made to meet the rigorous standards of the bioindustry, and cater to various biological products and their manufacturing processes. HZSKBIOⓇ is your trusted partner for quality control, whether you need ready-made products or custom solutions.
At Genetic Design and Manufacturing Corporation (GDMC), our mission is to exponentially increase the availability of genetic medicines and change millions of patients’ lives. We achieve this by partnering and supporting early-stage companies and investigators with innovative therapeutic modalities such as gene therapies or nucleic acids. Leveraging our expertise in process development and manufacturing, we accelerate our partners' ability to bring their ideas through clinical trials and into the market.
At BIOMAP, our conference promises to be an enlightening and inspiring experience, uniting the brightest minds in the CGT industry. We firmly believe that your partnership will play a pivotal role in ensuring the success of ACGT 2023, while also presenting a unique opportunity for your organization to engage with industry professionals and leaders.Become Partner